Literature DB >> 24055294

Development of specific scFv antibodies to detect neurocysticercosis antigens and potential applications in immunodiagnosis.

Vanessa da Silva Ribeiro1, Thaise Gonçalves Araújo, Henrique Tomaz Gonzaga, Rafael Nascimento, Luiz Ricardo Goulart, Julia Maria Costa-Cruz.   

Abstract

We have shown previously that detection of circulating antibodies against mimotopes selected by phage display were useful in neurocysticercosis diagnosis. However, circulating antigens may also be useful in patients' clinical follow-up. Therefore, we aimed to select novel combinatorial antibodies, single-chain variable fragment (scFv), which can be used for specific antigens with pre-defined affinity and specificity without prior immunization. A phage scFv antibody library was selected against Taenia solium mimotopes displayed on phages coupled in beads and total saline extract of T. solium metacestodes (S) immobilized on microtiter plate wells. After two rounds of selection, 96 phage clones were evolved and validated against each target by enzyme linked immunosorbent assay (ELISA), and dot-blot, and three specific antibodies (B6, G10 and A4) were further characterized by sequencing and indirect immunofluorescence (IFI) assays. IFI revealed tegument staining for the B6, while the others showed a non-uniform staining in the whole parasite. The selected scFvs were used to capture their antigen targets that were elucidated through mass spectrometry, and used for antibody detection in NC patients' sera by ELISA, which achieved sensitivities greater than 97% and specificities above 95%. We have successfully developed scFv antibodies against important mimotopes used in NC diagnosis, and can be further explored to detect circulating antigens for clinical follow-up of patients with NC. Our strategy also highlighted the possibility of using this combinatorial approach to select, capture and characterize specific antigens to better understand this intriguing parasite infection and disease evolution.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ELISA; Immunofluorescence; Phage displayed peptides; Taenia solium; scFv

Mesh:

Substances:

Year:  2013        PMID: 24055294     DOI: 10.1016/j.imlet.2013.09.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

Review 1.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

2.  Structural and functional characterization of a novel scFv anti-HSP60 of Strongyloides sp.

Authors:  Marcelo Arantes Levenhagen; Fabiana de Almeida Araújo Santos; Patrícia Tiemi Fujimura; Ana Paula Carneiro; Ana Paula Caneiro; Julia Maria Costa-Cruz; Luiz Ricardo Goulart
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

3.  Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.

Authors:  Lourena Emanuele Costa; Luiz Ricardo Goulart; Nathália Cristina de Jesus Pereira; Mayara Ingrid Sousa Lima; Mariana Costa Duarte; Vivian Tamietti Martins; Paula Sousa Lage; Daniel Menezes-Souza; Tatiana Gomes Ribeiro; Maria Norma Melo; Ana Paula Fernandes; Manuel Soto; Carlos Alberto Pereira Tavares; Miguel Angel Chávez-Fumagalli; Eduardo Antonio Ferraz Coelho
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 4.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.